Investor Stock List
Ranked #8,248 of 8,699 institutional investors

Omega Fund Management, LLC

Boston, MA

$81.8M
US stock portfolio at live prices · today +$1.1M (+1.34%)
Live prices, last trade 10:15 AM ET
Value at quarter end (Q3 2026)
$125M
Change from Q2 2026
−$60.5M (−32.59%)
Positions
8 · 1 new, 1 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$12.0M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
NUVB 34.0%BCAX 19.5%BBNX 16.1%BBOT 7.72%IMUX 3.82%
StockSharesValue, live% of portfoliovs Q2 2026
NUVB Nuvation Bio Inc.7,151,031$27.9M34.0%Reduced −12%
BCAX Bicara Therapeutics Inc.1,759,912$16.0M19.5%Reduced −3%
BBNX Beta Bionics, Inc.962,010$13.2M16.1%Reduced −27%
BBOT BridgeBio Oncology Therapeutics, Inc.3,289,661$6.3M7.72%Unchanged
IMUX Immunic, Inc.430,180$3.1M3.82%New
IMA ImageneBio, Inc.455,361$1.8M2.22%Unchanged
SANA Sana Biotechnology, Inc.843,750$1.4M1.77%Unchanged
ODTX Odyssey Therapeutics, Inc.2,893$49K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ALMS Alumis Inc.241,255$1.0M